Lexicon Pharmaceuticals is a biopharmaceutical company that uses a unique approach to gene science to develop treatments for people with serious and life-threatening conditions. The company's scientists have created an extensive library of genes and proteins that are potential drug targets using its proprietary gene knockout technology. Lexicon has clinical-stage drug programs for diabetes, neuropathic pain, carcinoid syndrome, and other indications. The company is headquartered in The Woodlands, Texas.